Baidu
map

中国非医用口罩抽查合格率达84.3%,产品质量趋势向好

2020-11-06 央视新闻 央视新闻

市场监管总局获悉:新冠肺炎疫情发生之后,口罩市场需求呈爆发式增长,口罩生产企业数量激增。市场监管总局等部门坚持协同作战,多次开展专项行动,严厉查处违法生产销售口罩等防护物资行为,全力保障口罩质量和市场

市场监管总局获悉:新冠肺炎疫情发生之后,口罩市场需求呈爆发式增长,口罩生产企业数量激增。市场监管总局等部门坚持协同作战,多次开展专项行动,严厉查处违法生产销售口罩等防护物资行为,全力保障口罩质量和市场供应。

经过各有关部门的共同努力,口罩等防疫物资产能迅速扩大,口罩市场供应和产品质量得到充分保障。数据显示,目前我国非医用口罩产品质量专项监督抽查合格率已达84.3%,全国12315平台日均受理口罩投诉数量较1月下旬降低96.1%,口罩质量违法案件大幅下降,产品质量趋势向好。

市场监管总局、国家发展改革委、工业和信息化部、商务部、海关总署、国家药监局等六部门近日联合印发《关于促进口罩产品质量提升的指导意见》,对今后一个时期口罩质量提升工作作出部署。市场监管部门下一步在口罩质量安全问题上,将继续从严监管,一方面压实企业主体责任,加强行业自律;一方面实施联动监管,协同共治,加大政策引导、支持和保障力度,强化质量帮扶,助力口罩行业增品种,提品质、创品牌,推动口罩行业健康有序发展。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1307870, encodeId=dbaf130e870f7, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Sun Nov 08 14:26:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591732, encodeId=bdf71591e32ed, content=<a href='/topic/show?id=cf7e34e2196' target=_blank style='color:#2F92EE;'>#医用口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34721, encryptionId=cf7e34e2196, topicName=医用口罩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f817994975, createdName=mgqwxj, createdTime=Sun Nov 08 14:26:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897457, encodeId=296089e45721, content=66666666666, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36b45432299, createdName=ms6000000915264790, createdTime=Fri Nov 06 23:43:30 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897456, encodeId=d9bb89e4569d, content=66666666666, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36b45432299, createdName=ms6000000915264790, createdTime=Fri Nov 06 23:43:11 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1307870, encodeId=dbaf130e870f7, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Sun Nov 08 14:26:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591732, encodeId=bdf71591e32ed, content=<a href='/topic/show?id=cf7e34e2196' target=_blank style='color:#2F92EE;'>#医用口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34721, encryptionId=cf7e34e2196, topicName=医用口罩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f817994975, createdName=mgqwxj, createdTime=Sun Nov 08 14:26:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897457, encodeId=296089e45721, content=66666666666, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36b45432299, createdName=ms6000000915264790, createdTime=Fri Nov 06 23:43:30 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897456, encodeId=d9bb89e4569d, content=66666666666, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36b45432299, createdName=ms6000000915264790, createdTime=Fri Nov 06 23:43:11 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1307870, encodeId=dbaf130e870f7, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Sun Nov 08 14:26:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591732, encodeId=bdf71591e32ed, content=<a href='/topic/show?id=cf7e34e2196' target=_blank style='color:#2F92EE;'>#医用口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34721, encryptionId=cf7e34e2196, topicName=医用口罩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f817994975, createdName=mgqwxj, createdTime=Sun Nov 08 14:26:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897457, encodeId=296089e45721, content=66666666666, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36b45432299, createdName=ms6000000915264790, createdTime=Fri Nov 06 23:43:30 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897456, encodeId=d9bb89e4569d, content=66666666666, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36b45432299, createdName=ms6000000915264790, createdTime=Fri Nov 06 23:43:11 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-06 ms6000000915264790

    66666666666

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1307870, encodeId=dbaf130e870f7, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Sun Nov 08 14:26:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1591732, encodeId=bdf71591e32ed, content=<a href='/topic/show?id=cf7e34e2196' target=_blank style='color:#2F92EE;'>#医用口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34721, encryptionId=cf7e34e2196, topicName=医用口罩)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=56f817994975, createdName=mgqwxj, createdTime=Sun Nov 08 14:26:48 CST 2020, time=2020-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897457, encodeId=296089e45721, content=66666666666, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36b45432299, createdName=ms6000000915264790, createdTime=Fri Nov 06 23:43:30 CST 2020, time=2020-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897456, encodeId=d9bb89e4569d, content=66666666666, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36b45432299, createdName=ms6000000915264790, createdTime=Fri Nov 06 23:43:11 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-06 ms6000000915264790

    66666666666

    0

相关资讯

BMJ Open:医院质量管理和患者因素之间关系的研究(DUQuA)

背景:尽管在医疗保健治疗和安全的研究不断增加,但很少有证据表明医院管理方式和患者因素的关系,限制了对大规模变化的了解。“加深对澳大利亚质量的了解“()研究旨在评估1组织和部门质量管理系统(QMS),临床医生的领导力和文化;2澳大利亚医院中临床治疗过程,临床预后和患者对护理评价部分。方法与分析:DUQuA是一项全国性,多层次,横断面的研究,在医院,科室,专业和患者水平收集数据。样本量至少43个医院才

CDS 2016:翁建平教授谈从质量改善探寻糖尿病防控出路

由中华医学会、中华医学会糖尿病学分会主办,厦门市医学会承办的中华医学会糖尿病学分会第二十次全国学术会议201611

EUR HEART J-CARD PHA:一些非专利心血管药物产品的低质量是一个日益引起关注的问题?

通用药品(GMP)是低价专利药品的复制品,可降低医疗保健成本并扩大获得医疗保健的机会。因此,卫生保健当局、专业人员和提供者推荐使用它们。

Lancet:质量改善策略可改善糖尿病治疗

  加拿大学者的一项荟萃分析表明,诸多试验表明质量改善策略可改善糖尿病治疗。以慢性病系统管理为靶向的干预策略,以及患者介导的质量改善策略应是改善糖尿病管理的重要组成部分。论文于2012年6月9日在线发表于《柳叶刀》(Lancet)杂志。   目前尚不清楚质量改善策略对糖尿病治疗的作用。研究者检索了Medline和Cochrane数据库以及相关参考文献,并纳入了对11项预定质量改善策略或财政奖励政

Baidu
map
Baidu
map
Baidu
map